相关实验视频
Updated: Sep 15, 2025

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.6K
精细化TSLP表达介导与IL22/STAT3轴相关的慢性全力发育
Chun-Ching Lu1, Ying-Yi Lu2, Hung-Pei Tsai3
1Department of Orthopaedics and Traumatology, National Yang Ming Chiao Tung University Hospital, Yilan, 260006, Taiwan; Department of Orthopaedics, School of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Neurochemistry international
|July 12, 2025
概括
向胸膜 stromal lymphopoietin (TSLP) 提供了一种新的方法来治疗慢性疼痛状况,如全管痛. 抑制TSLP可以降低神经炎症和神经元损失,通过调节IL22/STAT3通路来减轻疼痛.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性全音症是由于中枢神经系统的不适应性神经可塑性造成的.
- 干白素-22 (IL22) 是一种关键的调解物,具有促炎和免疫抑制作用.
- 胸膜 stromal 淋巴蛋白 (TSLP) 涉及炎症和免疫反应.
研究的目的:
- 为了研究调节TSLP表达的治疗潜力,慢性全体.
- 阐明TSLP在全体的作用背后的机制,特别是其与IL22通路的相互作用.
- 评估TSLP调制在体外的神经保护作用.
主要方法:
- 产生了TSLP淘汰赛 (KO) 鼠标,并将它们与在白素诱导的全体质条件下的野生类型 (WT) 鼠标进行比较.
- 施用了白素来诱导慢性全体运动,并评估了结晶症,神经元损失和机械戒断值.
- 利用分化的人类SH-SY5Y细胞来评估TSLP对过氧化引起的神经毒性的神经保护作用.
主要成果:
- 在WT小鼠中,布莱米辛诱导的慢性全氨与IL22/STAT3通路活性降低,滑症增加和神经元损失有关.
- 与WT小鼠相比,TSLP缺乏的小鼠表现出显著降低的滑症,神经元损失和改变的机械戒断值.
- TSLP缺乏保护SH-SY5Y细胞免受过氧化引起的神经毒性,IL22刺激进一步增强了这种保护.
结论:
- 缺乏TSLP可以通过降低TSLP受体 (TSLPR) /STAT5和IL22/STAT3轴的调节来降低神经炎症,神经毒性和慢性全体性.
- 抑制TSLP可以挽救IL22/STAT3介导的效应,调节神经质相互作用以缓解慢性全.
- 针对TSLP/TSLPR通路,通过减轻结晶症,神经元损失和神经炎症,为慢性全音症提供了一个有前途的治疗策略.
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K

